Zydus Cadila gets approval from USFDA for Acyclovir Sodium Injection

05 Sep 2018 Evaluate

Zydus Cadila has received final approval from US Food and Drug Administration (USFDA) to market Acyclovir Sodium Injection, 500 mg (base)/10 mL (50 mg (base)/ml) and 1,000 mg (base)/20mL (50 mg (base)/mL) single-dose vials (US RLD-Zovirax for injection). It will be manufactured at the group's formulations manufacturing facility at Moraiya in Ahmedabad.

Acyclovir is an antiviral drug. It slows the growth and spread of the herpes virus in the body. Acyclovir injection is used to treat severe infections caused by herpes viruses. The group now has 216 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

1008.50 11.05 (1.11%)
16-May-2024 15:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1535.60
Dr. Reddys Lab 5834.25
Cipla 1424.50
Zydus Lifesciences 1008.50
Lupin 1660.35
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.